Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » Half Year Financial Report
Half Year Financial Report
May 23, 2025 •
Category
•
Author Name
Half Year Financial Report
Latest News
BioDiem Shareholder Update
October 29, 2025
BioDiem Shareholder Update
Read More
BioDiem Update and EOFY 25 Information
August 6, 2025
BioDiem Update and EOFY 25 Information
Read More
